Crossmark

Low Dose Medicine: theoretical background and scientific evidence

Crossref DOI link: https://doi.org/10.1186/s13052-018-0460-6

Published Online: 2018-02-08

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bernasconi, S. https://orcid.org/0000-0002-1788-3052
More Information

Article History

Received: 27 November 2017

Accepted: 30 January 2018

First Online: 8 February 2018

Competing interests

: The author received some fees for lectures on the scientific results contained with the low dose medicine by the Guna Company- Milan-Italy which produces low dose cytchines. The lectures have been held inhospital setting.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.